Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
Downloads
Published
2019-04-18
Issue
Section
Research Articles
How to Cite
1.
Al-Momen H. Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study. Al-Kindy Col. Med. J [Internet]. 2019 Apr. 18 [cited 2024 Dec. 19];13(1):76-81. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/130